Abstract
The international literature, in restricted contexts but of considerable significance, has begun to highlight this issue, pointing out that in clinical trials of many diseases, there is often a tendency not to take adequate account of the numerical prevalence of the female sex in the general population, in addition to the biological differences between men and women [...]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
